Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1682 of 6351
-
New drug aims to tame severe eczema in kids and teens
Disease control CompletedThis trial was designed to evaluate the safety of SHR-1819 in children and adolescents with moderate-to-severe atopic dermatitis.
Phase 1/2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a diabetes drug help heart failure patients after valve surgery?
Disease control Recruiting nowThe goal of this trial is to to determine whether use of a novel SGLT2 inhibitor, Enavogliflozin 0.3 mg once daily is superior to placebo, when added to standard-of-care, in reducing the composite of major cardiovascular events and Heart Failure events (hospitalization for Heart …
Phase 4 • Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a gentle brain zap tame Hard-to-Treat seizures?
Disease control Recruiting nowThe goal of this clinical trial is to to obtain a significant decrease in seizure frequency in patients with refractory focal epilepsy after applying treatment of cathodal tDCS, compared to sham stimulation drug-resistant epileptic patient. The main questions it aims to answer ar…
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New diabetes shot could cut injections in half
Disease control CompletedThis is a study to evaluate the impact and efficacy of Efsubaglutide Alfa injection 3mg QoW on the treatment of type 2 diabetes patients with poor glycemic control after dietary and exercise intervention. Primary objective: To evaluate the effect and role of continuous treatmen…
Phase 2 • Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:54 UTC
-
Tailored brain zaps show promise for stroke recovery
Symptom relief Recruiting nowThe central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomark…
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New eczema drug shows promise in reducing itch and rash
Symptom relief OngoingThe purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Phase 2 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Could a single zap of radiation tame a stubborn racing heart?
Disease control Recruiting nowThis is a research study that aims to understand if giving a lower dose of treatment all at once is as effective and safe as dividing it into three smaller doses for patients with a heart condition called refractory ventricular tachycardia (VT). These patients have not exhibited …
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Can tiny cell packages reveal new targets for stomach cancer?
Knowledge-focused Recruiting nowThis is an observational study with a case control design. This study included patients with gastric cancer confirmed by pathological diagnosis of gastric tissue, and matched the control population according to age, gender, etc. In this study, researchers collected clinical infor…
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Probiotic powder could keep kids Cold-Free this winter
Prevention Recruiting nowRandomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy paedi…
Sponsor: Bioithas SL • Aim: Prevention
Last updated Jun 26, 2026 16:37 UTC
-
Can a longer course of TARPEYO tame kidney disease?
Disease control Recruiting nowThe goal of this clinical trial is to assess the efficacy and safety of extended TARPEYO® (delayed-release budesonide capsules) treatment in adult patients with primary IgA nephropathy who have completed 9 months of TARPEYO® 16 mg once daily treatment in real-world clinical pract…
Phase 4 • Sponsor: Calliditas Therapeutics AB • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Brain zaps + pill may ease twisted neck disorder
Symptom relief By invitation onlyThis study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal cervical dystonia. Previous research demonstrated that individualized TMS improved writing behavior in focal hand dystonia after …
Phase 2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Can a diabetes drug help the lungs? pioglitazone put to the test for pulmonary hypertension
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety and efficacy of Pioglitazone in people with Pulmonary Hypertension (PH) due to Chronic Lung Disease (CLD). The main question it aims to answer is: • Whether pioglitazone affects mitochondrial oxygen utilization in pati…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Firefighters' stress may show up in blood sugar — a wearable device puts it to the test
Knowledge-focused CompletedStress is known to cause physical structures in the brain to dysregulate, resulting in health problems like cancer, cardiac disease, metabolic disorders (obesity), and depression. Firefighters experience many of these diseases at higher rates than other occupations while also exp…
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
New asthma drug tezepelumab tested in everyday clinics
Disease control OngoingTezepelumab is a first-in-class human monoclonal antibody for uncontrolled severe asthma that acts at the top of the inflammatory cascade by targeting thymic stromal lymphopoietin (TSLP), a key epithelial cytokine inducing both Type 2 and non- Type 2 inflammatory pathways. Consid…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells take aim at rare Organ-Damaging disease
Disease control Recruiting nowSystemic light chain amyloidosis (AL amyloidosis) is the most common type of systemic amyloidosis, with diverse clinical manifestations and difficulties in diagnosis and treatment. AL amyloidosis may involve multiple organs; the kidney and heart are the most commonly involved org…
Early phase 1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New Alzheimer's pill shows promise in Mid-Stage trial
Symptom relief Stopped earlyResearchers want to learn if giving MK-1167 (the study medicine) along with acetylcholinesterase inhibitor (AChEI) therapy can improve symptoms of Alzheimer's disease dementia (AD dementia), such as memory and mental activity. AD dementia is the most common type of dementia. AChE…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New eye injection could shrink metastatic tumors in the eye
Disease control Recruiting nowThe primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.
Phase 2 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a common diabetes drug protect breast cancer survivors from insulin resistance?
Disease control Recruiting nowThis phase III trial evaluates how often women develop insulin resistance and type-2 diabetes and compares metformin with usual care to usual care alone in treating insulin resistance in women with stage I-III breast cancer after chemotherapy. Insulin resistance occurs when cells…
Phase 3 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill takes on tough lymphoma: early trial seeks tumor shrinkage
Disease control OngoingThe primary purpose of this study is to evaluate the anti-tumor activity of TLN-254 monotherapy in participants with relapsed or refractory T-cell lymphoma.
Phase 1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Are ventilated patients starving in silence? a new study investigates
Knowledge-focused CompletedThe primary objective is to quantify the caloric and protein intake in adult participants with acute respiratory failure who start a noninvasive ventilation treatment. The main question is: \- Are participants meeting their caloric and protein target during noninvasive ventilati…
Sponsor: Università degli Studi del Piemonte Orientale Amedeo Avogadro • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC